Search Site


Answer Centre - Telephone Answering in your Company Name by an Answer Centre PA


BioProgress gains EU accreditation for SoluPol application

16 August 2007

BioProgress, the specialty pharmaceutical and healthcare company has received Medical Device approvals from an EU Notified Body for two novel line extensions of the Artisial / Hypozalix xerostomia (dry mouth) treatment using SoluPol technology.

This regulatory approval equates to authorisation to sell the products to the general public in Europe and certain other markets such as South America and the Middle East.

Richard Trevillion, Chief Executive Officer, BioProgress said:

'Once again this accreditation demonstrates the strength of the Company's development pipeline. We are continually proving our ability to apply our enabling technologies to make products that reach the market and are able to deliver revenues which further increase shareholder value.'







Headlines

31 August 2010

30 August 2010

27 August 2010

20 August 2010

18 August 2010

13 August 2010

09 August 2010

06 August 2010

30 July 2010

29 July 2010

28 July 2010

27 July 2010

26 July 2010

23 July 2010

23 July 2010

22 July 2010

21 July 2010

19 July 2010

16 July 2010

12 July 2010

09 July 2010

08 July 2010

07 July 2010

06 July 2010

05 July 2010

02 July 2010

06 May 2010

13 April 2010

24 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

19 March 2010

19 March 2010

» See all News




© SmallCapNews   |   Contact Us   |   Terms of Use   |   RSS Feeds Site by LunarSafari